Proteomic changes in the human cerebrovasculature in Alzheimer’s disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid

Abstract INTRODUCTION Cerebrovascular dysfunction is a pathological hallmark of Alzheimer’s disease (AD). Nevertheless, detecting cerebrovascular changes within bulk tissues has limited our ability to characterize proteomic alterations from less abundant cell...